SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-017398
Filing Date
2022-11-10
Accepted
2022-11-10 16:01:25
Documents
13
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K capr-20221110x8k.htm   iXBRL 8-K 38017
2 EX-99.1 capr-20221110xex99d1.htm EX-99.1 157202
  Complete submission text file 0001558370-22-017398.txt   323838

Data Files

Seq Description Document Type Size
3 EX-101.SCH capr-20221110.xsd EX-101.SCH 2980
4 EX-101.LAB capr-20221110_lab.xml EX-101.LAB 15268
5 EX-101.PRE capr-20221110_pre.xml EX-101.PRE 9656
7 EXTRACTED XBRL INSTANCE DOCUMENT capr-20221110x8k_htm.xml XML 4728
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 221376889
SIC: 2834 Pharmaceutical Preparations